Blog

■ Ovarian expression of adipokines in polycystic ovary syndrome: A role for chemerin, omentin, and apelin in follicular growth arrest and ovulatory dysfunction?

Alice Bongrani, Namya Mellouk, Christelle Rame et al

Int J Mol Sci. 2019 Aug; 20(15): 3778

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695651/

 

■ Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?

Farnaz Shishehgar, Parvin Mirmiran, Maryam Rahmati, et al

BMC Endocr Disord. 2019; 19: 93

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720418/

 

■ Can the genetic polymorphisms of the folate metabolism have an influence in the polycystic ovary syndrome?

Santos, Tayssia Beatriz dos et al.

Arch. Endocrinol. Metab., Oct 2019, vol.63, no.5, p.501-508

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019000800501&lng=pt&nrm=iso

 

■ Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?.

Di, Na et al

Arch. Endocrinol. Metab., Apr 2019, vol.63, no.2, p.128-136

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019000200128&lng=pt&nrm=iso

 

■ Can resistance training improve the symptoms of polycystic ovary syndrome?

P Pericleous, S Stephanides

BMJ Open Sport Exerc Med 2018, vol 4 (1): e000372

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109818/

 

■ Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?.

Sahin, Murat et al.

Arch. Endocrinol. Metab., Mar 2017, vol.61, no.2, p.145-151

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000200145&lng=pt&nrm=iso

 

■ Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?

Rajani Dube

Avicenna J Med. 2016 Oct-Dec; 6(4): 91–102

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054651/

 

■ Síndrome dos Ovários Policísticos Online (Polycystic Ovary Syndrome)

Arquivo – dezembro 2018

https://internetmedica.com.br/sindrome-dos-ovarios-policisticos-online-polycystic-ovary-syndrome/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: Abril 2020

■ Novel Coronavirus Information Center

Elsevier´s free health and medical research on the novel coronavirus (SARS-CoV-2) and COVID-19 – updated april 2020

https://www.elsevier.com/connect/coronavirus-information-center

 

■ COVID-19: What has been learned and to be learned about the novel coronavirus disease

Ye Yi, Philip N.P. Lagniton, Sen Ye, Enqin Li, Ren-He Xu

Int J Biol Sci. 2020; 16(10): 1753–1766

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098028/

 

■ What can early Canadian experience screening for COVID-19 teach us avout how to prepare for a pandemic?

Molly Lin, Alina Beliavsky, Kevin Katz,  et al

CMAJ. 2020 Mar 23; 192(12): E314–E318

https://www.cmaj.ca/content/192/12/E314

 

Estimates of the severity of coronavirus disease 2019: a model-based analysis

R Verity, L C Okell, I Dorigatti et al

The Lancet Infectious Diseases march 30, 2020

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30243-7/fulltext

 

■ COVI-19: a remote assessment in primary care

T Greenhalgh, G C H Koh, J Car

BMJ 2020, vol 368: m1182

https://www.bmj.com/content/368/bmj.m1182

 

■ Coronavirus disease 2019 (covid-19): a guide for UK GPs

BMJ 2020, vol 368: m800

Na updated module from BMJ Best Practice

https://bestpractice.bmj.com/topics/en-gb/3000168#important-update

 

■ A review of coronavirus disease-2019 (COVID-19)

Tanu Singhal

Indian J Pediatr. 2020; 87(4): 281–286.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090728/

 

■ First case of 2019 novel coronavirus in the United States

Michelle L. Holshue, Chas DeBolt, Scott Lindquist, et al

N Engl J Med. 2020 Mar 5; 382(10): 929–936

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092802/

 

■ Research and development on therapeutic agentes and vacines for COVID-19 and related human coronavirus diseases

Cynthia Liu, Qiongqiong Zhou, Yingzhu Li, et al

ACS Cent Sci. 2020 Mar 25; 6(3): 315–331

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094090/

 

■ The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status

Yan-Rong Guo, Qing-Dong Cao, Zhong-Si Hong, Yuan-Yang

Mil Med Res. 2020; 7: 11

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068984/

 

■ COVID-19 and the cardiovascular system

Ying-Ying Zheng, Yi-Tong Ma, Jin-Ying Zhang, Xiang Xie

Nat Rev Cardiol. 2020 Mar 5 : 1–2

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095524/

 

■ The cardiovascular burden of coronavirus disease 2019 (COVID-19)

Weiyi Tan, Jamil Aboulhosn

Int J Cardiol. 2020 Mar 2

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102656/

 

■ Surviving sepsis Campaign: guidelines on the management of critically ill adullts with Coronavirus Disease 2019 (COVID-19)

Waleed Alhazzani, Morten Hylander Møller, Yaseen M. Arabi, et al

Intensive Care Med. 2020 Mar 28 : 1–34

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101866/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: abril 2020